Compugen Provides Q1 Earnings Update and Clinical Trial Progress
Compugen reported its first-quarter earnings for 2026, highlighting progress in clinical trials including the MAIA-ovarian study. The company remains on track to report interim data by early 2027 and noted strong cash reserves funding operations through 2029.